Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 of The Development of A Unified Treatment for Anxiety Disorders

NCT00586001 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.

NCT NCT00586001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 of The Development of A Unified Treatment for Anxiety Disorders
Lead sponsor
Boston University Charles River Campus
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2005
Completion date
November 30, 2010
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, emotional disorders